<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR24" class="ref">
 <span class="label" xmlns="http://www.w3.org/1999/xhtml">24.</span>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Ivashko</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">IN</span>
   </name>
   <name class="name">
    <span class="surname" xmlns="http://www.w3.org/1999/xhtml">Kolesar</span>
    <span class="given-names" xmlns="http://www.w3.org/1999/xhtml">JM</span>
   </name>
  </person-group>
  <div class="article-title" xmlns="http://www.w3.org/1999/xhtml">Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma</div>
  <div class="source" xmlns="http://www.w3.org/1999/xhtml">Am. J. Health-Syst. Pharm.</div>
  <span class="year" xmlns="http://www.w3.org/1999/xhtml">2016</span>
  <span class="volume" xmlns="http://www.w3.org/1999/xhtml">73</span>
  <span class="fpage" xmlns="http://www.w3.org/1999/xhtml">193</span>
  <span class="lpage" xmlns="http://www.w3.org/1999/xhtml">201</span>
  <span pub-id-type="doi" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">10.2146/ajhp140768</span>
  <?supplied-pmid 26843495?>
  <span pub-id-type="pmid" class="pub-id" xmlns="http://www.w3.org/1999/xhtml">26843495</span>
 </element-citation>
</ref>
